logo

For the Inventor, By the Inventor

Marloffstein, Germany

Kay Brune

This inventor holds 18 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Asta Medica, Aktiengesellschaft, Arzneimittelwerk Dresden Gmbh, Paz Arzneimittelentwicklungsgesellschaft Mbh. Active years: 1986-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kay Brune. Retrieved from https://idiyas.com/inventor/kay-brune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 77.8


Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 153(Granted Patents)


Location History:

  • Marloffstein/Rathsberg, DE (1999 - 2005)
  • Marloffstein, DE (1986 - 2013)

Company Filing History:

goldMedal5 out of 112 
 
Asta Medica, Aktiengesellschaft
 patents
silverMedal3 out of 39 
 
Arzneimittelwerk Dresden Gmbh
 patents
bronzeMedal3 out of 7 
 
Paz Arzneimittelentwicklungsgesellschaft Mbh
 patents
4. 2 out of 23 
 
Ludwig Heumann & Co. Gmbh
 patents
5. 1 out of 1 
 
Asta Medica Aktiengesellschgt
 patent
6. 1 out of 13 
 
Meda Pharma Gmbh & Co. Kg
 patents
7. 1 out of 1 
 
Pharmatrans Sanaq Ag
 patent
8. 1 out of 7 
 
Valeant Pharmaceuticals North America
 patents
9. 1 out of 1 
 
Ziophram Oncology, Inc.
 patent

Years Active: 1986-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Flupirtine
Sodium Channel Inhibitors
Indolyl-3-Glyoxylic Acid
Immunophilin Ligands
Antitumor Action
Anti-Asthmatic
Anti-Allergic
Neuroprotective Action
Benzothiazole Derivatives
Pharmaceutical Preparations
Medicaments
Immuno-Modulating
18 patents (USPTO):Explore Patents
1. 8557851 - Combinations of flupirtine and sodium channel inhibiting substances for treating pains (2013-10-15),
2. 7799832 - Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains (2010-09-21),
3. 7579365 - Indolyl-3-glyoxylic acid derivatives having antitumor action (2009-08-25),
4. 6919344 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2005-07-19),
5. 6344467 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2002-02-05),
6. 6258815 - Specific immunophilin ligands as antiasthmatics and immunosuppressants (2001-07-10),
7. 6251932 - Immunophilin ligands (2001-06-26),
8. 6232327 - Indolyl-3-glyoxylic acid derivatives having antitumor action (2001-05-15),
9. 6180637 - 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments (2001-01-30),
10. 6166023 - 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, (2000-12-25),
11. 616602 - 1,5- and 3-O-substituted 1H-indazoles having anti-asthmatic, (2000-12-26),
12. 6066465 - Process for the diagnostic assessment and monitoring, as well as (2000-05-23),
13. 6008231 - N-substituted indole-3 glyoxylamides having anti-asthmatic antiallergic (1999-12-28),
14. 5565613 - 2-arylpropionic acid preparations and process for their production (1996-10-15),
15. 5206029 - Medicament and its production and use in the treatment of pain, (1993-04-27),

Title: The Innovative Journey of Kay Brune

Introduction:

Kay Brune, a talented inventor hailing from Marloffstein, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Kay Brune's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights:

Throughout his illustrious career, Kay Brune has been recognized for his innovative spirit and problem-solving abilities. His inventions have not only improved the quality of life for many but have also paved the way for future technological advancements.

Collaborations:

Kay Brune has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, Kay Brune's passion for innovation and his dedication to creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…